|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2009-6-24
|
|
pubmed:abstractText |
We have previously shown that in early clinical stage esophageal adenocarcinoma, a positron emission tomography standardized uptake values (PET SUVmax) of <4.5 is associated with earlier pathologic stage and predicts better survival. In this study, we analyze the impact of the pretreatment PET SUVmax in patients with locally advanced esophageal adenocarcinoma who undergo preoperative chemoradiotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1556-1380
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
875-9
|
|
pubmed:meshHeading |
pubmed-meshheading:19487968-Adenocarcinoma,
pubmed-meshheading:19487968-Chi-Square Distribution,
pubmed-meshheading:19487968-Esophageal Neoplasms,
pubmed-meshheading:19487968-Esophagogastric Junction,
pubmed-meshheading:19487968-Female,
pubmed-meshheading:19487968-Fluorodeoxyglucose F18,
pubmed-meshheading:19487968-Humans,
pubmed-meshheading:19487968-Male,
pubmed-meshheading:19487968-Middle Aged,
pubmed-meshheading:19487968-Predictive Value of Tests,
pubmed-meshheading:19487968-Prognosis,
pubmed-meshheading:19487968-Radiopharmaceuticals,
pubmed-meshheading:19487968-Retrospective Studies,
pubmed-meshheading:19487968-Survival Rate,
pubmed-meshheading:19487968-Whole Body Imaging
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Predictive value of initial PET-SUVmax in patients with locally advanced esophageal and gastroesophageal junction adenocarcinoma.
|
|
pubmed:affiliation |
Memorial Sloan-Kettering Cancer Center, New York City, New York 10021, USA. rizkn@mskcc.org
|
|
pubmed:publicationType |
Journal Article
|
